Nebulizing solnAdult & childn 2.5-5 mg. May repeat qid by nebulizer. Delivery of aerosol may be by face mask of "T" piece. Use undiluted. For prolonged delivery time, dilute w/ sterile water or normal saline for inj. MDIAdult & elderlyRelief of acute asthma symptoms including bronchospasm Initially 1 inhalation as single dose. May be increased to 2 inhalations. Prevention of allergen- or exercise-induced symptoms 2 inhalations 10-15 min before exertion. Chronic therapy 2 inhalations up to qid. Max: 8 inhalations/day.
Hyperthyroidism, arrhythmia, tachycardia, occlusive vascular disorders eg, arteriosclerosis, HTN, DM. Nebulizing soln: Thyrotoxicosis, CV diseases eg, ischemic heart disease, aneurysms. Angina pectoris, closed-angle glaucoma. MDI: Myocardial insufficiency, susceptibility to QT-interval prolongation. Obstructive cardiomyopathy & other disorders where reduction in total peripheral resistance could be harmful; pheochromocytoma. Monitor plasma K conc in patients w/ severe asthma who may be at risk for hypokalemia potentiated by hypoxia & concomitant use w/ other antiasthma drugs. Pregnancy & lactation.
R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Sign Out
